Week 345 Review - Big recovery but still below injection amount

This week saw a massive recovery in OPTI:Optibiotix to claw back £14,712 of the recent losses and reduce the deficit between cost and value to £63,589. The overall value went up to £95,371, but that's still less than I've put in so we're still in a sorry state, but not as sorry as last week.

Biggest loser was JLP:Jubilee Metals which dropped 16% of my purchase price and is still well below what I expected given metal prices and imminent copper revenue.

CEY:Centamin have pretty underwhelming results and were hammered, dropping 10% to go 23% down altogether.

IGG:IG Group have been slowly sneaking up, and climbed another 6% this week. They are only 8% down, which makes them one of my best performing shares. Could I finally get a magic formula share back in the black?

TLOU:Tlou Energy are making great progress and market seems to be slowly waking up to it. They went up 6% but are still half the price of the share options I have, so there's not going to be any incentive to take them up unless there's a re-rate.

ASHM:Ashmore Group have been suffering recently but went up 8% this week. They are still 14% down and I do regret buying them as they are exposed to some pretty big risks. Sometimes there's a good reason for a company to be at the top of the magic formula ranking, and I ought to assess the risks in future before piling in.

Share of the Week is OPTI:Optibiotix which went up by 8p which is 13%. This was mainly on the back of the announcement that they are splitting out the Probiotics division and floating it on the market. Thankfully OPTI shareholders are getting an allocation of shares, and I should get around 60,000 which will be nice. I'll treat the value of the shares as a dividend and add their cost to my portfolio cost else it will screw up all my figures if I have them at cost £0. I guess on ex dividend day the OPTI share price will drop about 20p so I should be prepared for a disastrous week. Only a Sweetbiotix announcement can save us.

Almost back up to the injection line but not quite

We have hit the trend line though. I long to be the other side of it...

Here's the ISA and shares portfolio after week 33 of year 7.

			Weekly Change
Cash	£25.80		+£0
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£42,488.90	(-41.1%)	+£7,081.92
Potential profits	£2,015.29		-£140.00
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£480.63	(13.0%)	-£15.02
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£362.31	(9.8%)	-£1.06
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

Potential profit dropped £140 thanks to JLP:Jubilee Metals which is still my only profitable share in this account. SBTX:SkinBioTherapeutics is only 5% down so hopefully that can contribute soon.

Massive increase in value reducing the deficit by 10% and sowing a seed of hope.

As with the combined chart, still below injection line

Still below trend line on this one.

The SIPP looks like this after week 329 overall and week 17 of year 7.

			Weekly Change
Cash	£100.18		-£0.27
Portfolio cost	£84,005.89		+£0
Portfolio sell value (bid price - commission)	£51,670.50	(-38.5%)	+£7,617.53
Potential profits	£40.51		-£90.00
Yr 7 Dividends	£96.57		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£526.22		+£0
Yr 7 projected avg monthly profit	£141.87	(3.3%)	-£8.94
Total Dividends	£3,300.96		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,250.85		+£0
Average monthly cash profit	£351.19	(8.1%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	51%		+0%

Cash dropped by the AJ Bell SIPP fee. Potential profits dropped thanks to SBTX:SkinBiotherapeutics dropping to only 90p potential profit, and iShares Physical Gold also dropped.

Same story as the ISA with huge gains mostly thanks to OPTI:Optibiotix

So close to the injection line, but below it.

Above the trend line!

The trading account looks like this after week 295 overall and week 35 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£826.82	(-65.2%)	+£13.11
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£14.66	(7.4%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

A tiny increase and still generally a disaster.

No hope of anything nice happening here

However, we're above the trend line so things could be looking up!

Ex-dividend date for OPTI:Optibiotix is Thursday so I'm expecting a massive drop in share price that day. If it's 20p as I fear, then it will remove £35,000 from my portfolio value. However, if I get 60,000 shares that will add £12,000 to my dividends so it could get a bit complicated.

It will also mean the OPTI share price drops to 20p which would be crazy with Sweetbiotix coming along. I desperately need there to be good news early next week to prevent a wipe-out.